| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/08/2009 | EP2076769A2 High througput methods for characterization of antibodies |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076543A2 Methods of reducing phosphate absorption |
| 07/08/2009 | EP2076542A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 07/08/2009 | EP2076541A2 Il-17 receptor a antigen binding proteins |
| 07/08/2009 | EP2076540A2 Novel anti-cd38 antibodies for the treatment of cancer |
| 07/08/2009 | EP2076539A2 Antibody molecules which bind il-17a and il-17f |
| 07/08/2009 | EP2076538A2 Materials and methods for improved immunoglycoproteins |
| 07/08/2009 | EP2076534A1 Peptides with high affinity for the prolactin receptor |
| 07/08/2009 | EP2076286A2 Methods of reducing phosphate absorption |
| 07/08/2009 | EP2076276A2 Sol-gel materials for cellular modulation |
| 07/08/2009 | EP1732588B1 Modulation of nkg2d |
| 07/08/2009 | EP1664121B1 Antibodies against interleukin-1 receptor and uses thereof |
| 07/08/2009 | EP1601683A4 Novel non-invasive marker for liver disease |
| 07/08/2009 | EP1434596B1 Enhancement of immune responses by agonist 4-1bb-antibodies |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1360281B1 Regulation of human wee1-like serine/threonine protein kinase |
| 07/08/2009 | EP1265929B1 Anti-c2/c2a inhibitors of complement activation |
| 07/08/2009 | EP1098658B1 Engineered proteins for analyte sensing |
| 07/08/2009 | EP0669988B2 Angiogenesis inhibitory antibodies |
| 07/08/2009 | CN101479296A TRAIL receptor-binding agents and uses of the same |
| 07/08/2009 | CN101475639A Mixed yolk antibody for preventing and treating duck infectious serositis and preparation thereof |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN100509851C Anti-alpha*beta* antibodies |
| 07/08/2009 | CN100509850C Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 07/08/2009 | CN100509849C Soluble human CD28 molecule detection kit and use thereof |
| 07/08/2009 | CN100509848C Preparation and use of monoclonal antibody against human OX40L |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/07/2009 | USRE40831 Passive immunotherapy; hybridoma cell line and antibodies produced by the cell lines; prevention and treatment of HBV infection |
| 07/07/2009 | US7557263 Methods of increasing polypeptide accumulation in plants |
| 07/07/2009 | US7557204 CUDR as biomarker for cancer progression and therapeutic response |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557193 Monoclonal antibody with binding specificity for lycosylated bile salt dependent lipase (BSDL) or fetoacinar pancreatic protein (FAPP) recognized by induced antibodies in a patient suffering from type I diabetes and purified from biological fluids of human or animal origin; hybridoma |
| 07/07/2009 | US7557192 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 07/07/2009 | US7557191 Sialoadhesin factor-2 antibodies |
| 07/07/2009 | US7557190 Epithelial cell adhesion molecule (Ep-CAM) antibodies; cytotoxic chemotherapeutics; antitumor agents |
| 07/07/2009 | US7557189 Immunoconjugates; screening for antibodies with improved affinity to CD 33 antigen; diagnosis of chronic myeloid leukemia (CML) and promyelocytic leukemia (PML); treating cancer |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557185 Moraxella catarrhalis proteins |
| 07/07/2009 | US7557084 IL-18 specific polypeptides and therapeutic uses thereof |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7557078 Morphogen-induced nerve regeneration and repair |
| 07/07/2009 | US7556955 Nucleic acids encoding Candida kefyr cytosine deaminase |
| 07/07/2009 | US7556928 Using biotin matrix to confine and analyze cell and its secretory components in microdrop; gel microdrop (GMD) secretion assay |
| 07/07/2009 | US7556927 Methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/07/2009 | US7556925 Treating or preventing an alpha nu beta 3 integrin mediated disease or disorder; , imaging tissues using positron emission tomography or magnetic resonance imaging, assessing the metastatic characteristics of a tumor, and delivering DNA to a cell |
| 07/07/2009 | US7556920 Polypeptide that forms part of a ubiquitin-ligase complex involved in targeting proteins by ubiquitination for degradation by the proteasome; cancer (breast and prostate carcinoma), immune/inflammatory disease and neurological disease |
| 07/07/2009 | US7556815 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 07/07/2009 | US7556804 Monoclonal antibodies which recognize the chain of hepatocyte growth factor receptor (HGF) receptor with the agonist activity of the natural ligand; hybridoma and the antibodies it secretes; inhibiting apoptotic damage to cells ; cardioprotective and hepatoprotective drugs |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/02/2009 | WO2009082624A2 Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| 07/02/2009 | WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 07/02/2009 | WO2009081854A1 Biomarker for allergic disease and utilization of the same |
| 07/02/2009 | WO2009081201A2 BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Rα) - 173 |
| 07/02/2009 | WO2009081069A2 Polyclonal antibody directed against the elastin binding protein and method for obtaining same |
| 07/02/2009 | WO2009080832A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | WO2009080831A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates |
| 07/02/2009 | WO2009080830A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080829A1 Agents targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080753A1 Pm-2 antibodies and methods for treating metastasis |
| 07/02/2009 | WO2009080278A1 Stability testing of antibodies |
| 07/02/2009 | WO2009080254A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080253A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080252A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080251A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 07/02/2009 | WO2009079793A1 Non-aggregating human vh domains |
| 07/02/2009 | WO2009052374A3 Igm-mediated receptor clustering and cell modulation |
| 07/02/2009 | WO2009052179A3 Feline pancreatic lipase |
| 07/02/2009 | WO2009004066A3 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions |
| 07/02/2009 | WO2008156622A8 Humanized antibodies to amyloid beta |
| 07/02/2009 | WO2008151088A8 Immunoglobulin constant region fc receptor binding agents |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | WO2008031577A8 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 07/02/2009 | WO2007134876A8 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 07/02/2009 | WO2007090675A8 Novel oxidoreductases and uses thereof |
| 07/02/2009 | US20090171072 Process for Preparing Unaggregated Antibody FC Domains |
| 07/02/2009 | US20090171071 PYY Agonists and Uses Thereof |
| 07/02/2009 | US20090170792 Peptide ligands |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170220 Bispecific capturing molecule |
| 07/02/2009 | US20090170219 Nucleic acid capable of binding to immunoglobulin G and use thereof |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170173 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii |
| 07/02/2009 | US20090170166 Antibody inhibiting uracil-dna-glycosylase and uses thereof for decontaminating nucleic acid amplification reactions |
| 07/02/2009 | US20090170163 Spacers to increase the expression of recombinant fusion proteins |
| 07/02/2009 | US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170138 DETERMINING CANINE proBNP |
| 07/02/2009 | US20090170137 DETERMINING CANINE proBNP |
| 07/02/2009 | US20090170136 DETERMINING FELINE proBNP |
| 07/02/2009 | US20090170135 DETERMINING FELINE proBNP |
| 07/02/2009 | US20090170130 Phosphospecific Chemokine Receptor Antibodies |
| 07/02/2009 | US20090170126 Prostasin Partial Peptide and Anti-Prostasin Antibody |
| 07/02/2009 | US20090170125 Cellular assay method for identifying pkc-0 inhibitors |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto |
| 07/02/2009 | US20090170063 Hcv rna having novel sequence |